The FDA announced it would give priority review to Eliquis, an anticlotting drug produced by Bristol-Myers Squibb and Pfizer, according to a Wall Street Journal report.
The drug works to prevent strokes in people with a heart-rhythm disorder called atrial fibrillation. An FDA decision could come as early as March 28, 2012.
Related Articles on FDA Approvals:
FDA Approves Expansion of BioMarin Pharma Plant
FDA Approves Philips' PET and MRI Whole Body Scanning System
FDA Approves New Boston Scientific Heart Stent
The drug works to prevent strokes in people with a heart-rhythm disorder called atrial fibrillation. An FDA decision could come as early as March 28, 2012.
Related Articles on FDA Approvals:
FDA Approves Expansion of BioMarin Pharma Plant
FDA Approves Philips' PET and MRI Whole Body Scanning System
FDA Approves New Boston Scientific Heart Stent